I traded straight after OSL announced the Oct CE Mark evaluation. But I'm certainly not going to be a holder across the binary decision from BSI though.
I agree with legume. The number of patients that have been evaluated is ridiculously small and without the rigorous control group comparison that you'd expect for a PhIII.
Whilst I like the technology and it looks promising, I'd be shocked if the EU device system allowed injection of radioactive substances with such statistically shallow evidence.
So I'm torn. Hope it goes well for holders, but I don't think it would be a sound decision if they let it through. I'll watch from the sidelines.
Dear Legume, page-25
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $27.18M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $80.49K | 9.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 11434962 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 5541905 | 5 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |